Bragar Eagel & Squire, PC announces class action lawsuit against Exscientia plc.Investors are encouraged to contact the company through Investing.com



NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, announces that it has filed a class action lawsuit against Exscientia plc. (Exscientia or the Company) (Nasdaq: EXAI) in the U.S. District Court for the District of New Jersey on behalf of all persons and entities that purchased or otherwise acquired Exscientia securities between March 23, 2022, and February 12, 2024 File a lawsuit. Investors have until June 25, 2024 to apply to the court to be appointed as lead plaintiff in the lawsuit.

Click here to join the action.

Exscientia is a pharmaceutical technology company powered by artificial intelligence (“AI”) that designs and develops differentiated medicines for diseases with unmet patient needs.

At all relevant times, the company claimed to “maintain[] “The highest standards of business conduct and ethics” and to this end adopted a Code of Business Conduct and Ethics applicable to all employees, officers and directors, including former Chief Executive Officer (“CEO”) and Director Defendant Andrew Hopkins ( Andrew Hopkins (“Hopkins”), defendant David Nickerson (“Nickerson”), the former chairman of the Company's board of directors (the “Board”), and all other senior officers and executives.

The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements about the company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Defendant Hopkins had inappropriate relationships with employees that were inconsistent with the Company's standards and values; (ii) Defendant Ni Colson had prior knowledge of Defendant Hopkins' relationship and improperly addressed Hopkins' misconduct without consulting the Committee; (iii) the Company's maintenance and enforcement of its Code of Business Conduct and Ethics was insufficient to prevent the conduct described above; (iv) the failures described above exposed the Company to a greater risk of a disruptive leadership transition and/or reputational damage; (v) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

3rd party advertising. Not an offer or recommendation by Investing.com.See disclosures here or
Remove ads
.

On February 13, 2024, Exscientia issued a press release “announced[ing] Its board of directors (the “Board”) has decided to terminate the employment [Defendant] Hopkins as a company [CEO] and Chief Executive Officer, and to remove Dr. Hopkins from his duties as Executive Director of the Board of Directors, in each case with cause and with immediate effect. Established relationships with two employees whom the Board deemed inappropriate and inconsistent with company standards and values.[Defendant] Nicholson [. . .] had prior knowledge of the existence of Dr. Hopkins' earlier relationship and handled the situation directly, with the involvement of other outside consultants, rather than in consultation with the Board,” and “[f]Following discussions with the Board of Directors, Dr. Nicholson resigned from the Company on February 12, 2024.

Affected by this news, Exscientia's stock price fell by $1.72 per share, or 22.9%, to close at $5.79 per share on February 13, 2024.

If you purchased or otherwise acquired Exscientia stock and suffered a loss, are a long-term shareholder, have information, would like to learn more about these claims, or have any questions about this announcement or your rights or interests with respect to these matters, please contact us at Contact Brandon Walker or Marion Passmore by emailing surveys@bespc.com, calling (212) 355-4648 or filling out this contact form. There is no cost or obligation to you.

3rd party advertising. Not an offer or recommendation by Investing.com.See disclosures here or
Remove ads
.

About Bragar Eagel & Squire, PC:

Bragar Eagel & Squire, PC is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivatives and other complex litigation in state and federal courts across the country.For more information about the company, please visit www.bespc.com. Lawyer advertising. Previous results do not guarantee similar results.

Contact information:

Bragar Eagel & Squire, PC
Mr. Brandon Walker

Mr Marion Passmore
(212)355-4648
surveys@bespc.com
www.bespc.com





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *